
Team Collaboration Software Market Share, Size, Trends, Industry Analysis Report, By Software (Conferencing, Communication & Coordination); By Application; By Deployment; By Region; Segment Forecast, 2021 - 2028
Description
The global team collaboration software market size is expected to reach USD 70.41 billion by 2034 according to a new study by Polaris Market Research. The report “Team Collaboration Software Market Share, Size, Trends, Industry Analysis Report, By Software (Conferencing, Communication & Coordination); By Application; By Deployment; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The perceptible factors esteeming the team collaboration platform growth include the rise in trend among companies for the implementation of smart meeting solutions with the ever-increasing rate of adoption of connected devices. In addition, the surge focus towards the bring-you-own-device (BYOD) devices and increasing usage tools to efficiently manage business projects are the few integral factors accelerating the industry growth during the forecasting years.
In the current scenario, the COVID-19 pandemic is spreading all over the world, and tapping societies, including businesses and individuals. Thus, several regional governments have implemented strict lockdowns and social distancing policies to reduce the widespread of novel coronavirus. Owing to this, the IT and telecom sector is playing a considerable role during the pandemic scenario to aid the digital infrastructure across the globe. Besides, with COVID-19, the overall workforce has experienced a significant transition toward remote working, paving a demand for team collaboration platform worldwide.
Market Participants such as Bluebeam, Inc., Amazon Web Services, Inc., Asana, Inc., Trello, Smart Technologies, Airtable, Zoom Video Communications, Inc., Box, Cisco Systems, Inc, Fuze, Inc., Salesforce.com, inc., Google LLC, International Business Machines Corporation, Jostle Corporation, Liquid Planner, Inc., Kintone Corporation, Microsoft Corporation, nTask, Oracle, Slack Technologies, LLC, Wrike, Inc., AT&T Intellectual Property, and Avaya Inc. are some of the key players operating in the global market.
Several manufacturers are often backing to opt for varied marketing strategies to expand their business operations globally. In May 2021, Microsoft corporation launched a new employee engagement platform, “Microsoft Viva,” which brings employees for work management, knowledge discovery, and learning, which thriving culture engages employees and employers.
Similarly, in July 2021, Meister, a cloud-based workplace developer, raised USD 52 million of funding to address and resolve workload management. Such initiatives drastically contribute towards the higher growth of the global team collaboration platform.
Polaris Market Research has segmented the team collaboration software market report on the basis of software, application, deployment, and region:
Team Collaboration Software, Software Outlook (Revenue, USD Billion, 2020 - 2034)
Conferencing
Communication & Coordination
Team Collaboration Software, Application Outlook (Revenue, USD Billion, 2020 - 2034)
Manufacturing
BFSI
IT & Telecom
Retail
Healthcare
Logistics & Transportation
Education
Team Collaboration Software, Deployment Outlook (Revenue, USD Billion, 2020 - 2034)
Cloud
On-Premises
Team Collaboration Software, Regional Outlook (Revenue, USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The perceptible factors esteeming the team collaboration platform growth include the rise in trend among companies for the implementation of smart meeting solutions with the ever-increasing rate of adoption of connected devices. In addition, the surge focus towards the bring-you-own-device (BYOD) devices and increasing usage tools to efficiently manage business projects are the few integral factors accelerating the industry growth during the forecasting years.
In the current scenario, the COVID-19 pandemic is spreading all over the world, and tapping societies, including businesses and individuals. Thus, several regional governments have implemented strict lockdowns and social distancing policies to reduce the widespread of novel coronavirus. Owing to this, the IT and telecom sector is playing a considerable role during the pandemic scenario to aid the digital infrastructure across the globe. Besides, with COVID-19, the overall workforce has experienced a significant transition toward remote working, paving a demand for team collaboration platform worldwide.
Market Participants such as Bluebeam, Inc., Amazon Web Services, Inc., Asana, Inc., Trello, Smart Technologies, Airtable, Zoom Video Communications, Inc., Box, Cisco Systems, Inc, Fuze, Inc., Salesforce.com, inc., Google LLC, International Business Machines Corporation, Jostle Corporation, Liquid Planner, Inc., Kintone Corporation, Microsoft Corporation, nTask, Oracle, Slack Technologies, LLC, Wrike, Inc., AT&T Intellectual Property, and Avaya Inc. are some of the key players operating in the global market.
Several manufacturers are often backing to opt for varied marketing strategies to expand their business operations globally. In May 2021, Microsoft corporation launched a new employee engagement platform, “Microsoft Viva,” which brings employees for work management, knowledge discovery, and learning, which thriving culture engages employees and employers.
Similarly, in July 2021, Meister, a cloud-based workplace developer, raised USD 52 million of funding to address and resolve workload management. Such initiatives drastically contribute towards the higher growth of the global team collaboration platform.
Polaris Market Research has segmented the team collaboration software market report on the basis of software, application, deployment, and region:
Team Collaboration Software, Software Outlook (Revenue, USD Billion, 2020 - 2034)
Conferencing
Communication & Coordination
Team Collaboration Software, Application Outlook (Revenue, USD Billion, 2020 - 2034)
Manufacturing
BFSI
IT & Telecom
Retail
Healthcare
Logistics & Transportation
Education
Team Collaboration Software, Deployment Outlook (Revenue, USD Billion, 2020 - 2034)
Cloud
On-Premises
Team Collaboration Software, Regional Outlook (Revenue, USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
112 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. U.S. Antibiotics Market Insights
- 4.1. U.S. Antibiotics Market – Market Snapshot
- 4.2. U.S. Antibiotics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Aging Population and Chronic Diseases
- 4.2.1.2. Rising Prevalence of Infectious Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Antibiotic Resistance and Regulatory Hurdles
- 4.2.3. Public opinion and privacy legal precedents
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. U.S. Antibiotics Market Trends
- 4.6. Value Chain Analysis
- 5. U.S. Antibiotics Market, By Drug Class
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. U.S. Antibiotics Market, By Drug Class, 2020–2034 (USD Billion)
- 5.3. Cephalosporin
- 5.3.1. U.S. Antibiotics Market, by Cephalosporin,2020–2034 (USD Billion)
- 5.4. Penicillin
- 5.4.1. U.S. Antibiotics Market, by Penicillin,2020–2034 (USD Billion)
- 5.5. Fluoroquinolone
- 5.5.1. U.S. Antibiotics Market, by Fluoroquinolone,2020–2034 (USD Billion)
- 5.6. Macrolides
- 5.6.1. U.S. Antibiotics Market, by Macrolides,2020–2034 (USD Billion)
- 5.7. Carbapenems
- 5.7.1. U.S. Antibiotics Market, by Carbapenems,2020–2034 (USD Billion)
- 5.8. Aminoglycosides
- 5.8.1. U.S. Antibiotics Market, by Aminoglycosides,2020–2034 (USD Billion)
- 5.9. Sulfonamides
- 5.9.1. U.S. Antibiotics Market, by Sulfonamides,2020–2034 (USD Billion)
- 5.10. 7-ACA
- 5.10.1. U.S. Antibiotics Market, by 7-ACA,2020–2034 (USD Billion)
- 5.11. Others
- 5.11.1. U.S. Antibiotics Market, by Others,2020–2034 (USD Billion)
- 6. U.S. Antibiotics Market, By Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. U.S. Antibiotics Market, By Type, 2020–2034 (USD Billion)
- 6.3. Branded Antibiotics
- 6.3.1. U.S. Antibiotics Market, by Branded Antibiotics,2020–2034 (USD Billion)
- 6.4. Generic Antibiotics
- 6.4.1. U.S. Antibiotics Market, by Generic Antibiotics,2020–2034 (USD Billion)
- 7. U.S. Antibiotics Market, By Action Mechanism
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. U.S. Antibiotics Market, By Action Mechanism, 2020–2034 (USD Billion)
- 7.3. Cell Wall Synthesis Inhibitors
- 7.3.1. U.S. Antibiotics Market, by Cell Wall Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.4. Protein Synthesis Inhibitors
- 7.4.1. U.S. Antibiotics Market, by Protein Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.5. DNA Synthesis Inhibitors
- 7.5.1. U.S. Antibiotics Market, by DNA Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.6. RNA Synthesis Inhibitors
- 7.6.1. U.S. Antibiotics Market, by RNA Synthesis Inhibitors,2020–2034 (USD Billion)
- 7.7. Mycolic Acid Inhibitors
- 7.7.1. U.S. Antibiotics Market, by Mycolic Acid Inhibitors,2020–2034 (USD Billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Cumberland Pharmaceuticals, Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Entasis Therapeutics (now part of Innoviva)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Melinta Therapeutics LLC
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Merck & Co., Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Nabriva Therapeutics PLC
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Paratek Pharmaceuticals, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Pfizer Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Spero Therapeutics
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Venatorx Pharmaceuticals
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Viatris, Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.